Literature DB >> 27049297

Prevalence and Metrics Distribution of Ideal Cardiovascular Health: A Population-based, Cross-sectional Study in Rural China.

Ye Chang1, Xiaofan Guo1, Yintao Chen1, Liang Guo1, Zhao Li1, Shasha Yu1, Hongmei Yang1, Guozhe Sun1, Yingxian Sun2.   

Abstract

BACKGROUND: The American Heart Association (AHA) introduced definitions of "ideal," "intermediate," and "poor" cardiovascular health (CVH) based on seven cardiovascular health metrics (smoking, body mass index, physical activity, diet score, total cholesterol, blood pressure, and fasting glucose). This study used this construct to assess the prevalence and metric distribution of CVH in a rural population with traditional lifestyles and investigate the relationship of CVH with socio-demographic characteristics of participants.
METHODS: From January 2012 to August 2013, a representative sample of 11,113 adults (mean age 53.8±10.6 years; 53.8% women) was enrolled from a rural population in Northeast China using a multi-stage, stratified random cluster-sampling scheme.
RESULTS: According to the adjusted AHA criteria for CVH health metrics, there was 0.1% prevalence of ideal CVH (all seven health metrics at ideal levels), 11.7% of intermediate CVH (at least one health metric at intermediate level, but no poor health metrics), and 88.2% of poor CVH (at least one of seven health metrics at poor level). Women and young/middle-aged adults were more likely to have all of the ideal CVH metrics, behaviours, factors and CVH status.
CONCLUSIONS: Our study showed extremely low (0.1%) prevalence of ideal CVH in the rural population of northeast China. The poor CVH status, particularly among men and older individuals, underscores the need for urgent action on modifiable risk factors, especially blood pressure and smoking.
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease risk factors; Epidemiology; Ideal cardiovascular health; Prevention

Mesh:

Year:  2016        PMID: 27049297     DOI: 10.1016/j.hlc.2016.02.007

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  13 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study.

Authors:  Xiaolei Han; Ziying Jiang; Yuanjing Li; Yongxiang Wang; Yajun Liang; Yi Dong; Shi Tang; Yifeng Du; Chengxuan Qiu
Journal:  BMC Geriatr       Date:  2021-03-04       Impact factor: 3.921

3.  The Association of Ideal Cardiovascular Health and Atherogenic Index of Plasma in Rural Population: A Cross-Sectional Study from Northeast China.

Authors:  Ye Chang; Yuan Li; Xiaofan Guo; Dongxue Dai; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-10-19       Impact factor: 3.390

4.  The Prevalence of Hypertension Accompanied by High Homocysteine and its Risk Factors in a Rural Population: A Cross-Sectional Study from Northeast China.

Authors:  Ye Chang; Yuan Li; Xiaofan Guo; Yintao Chen; Dongxue Dai; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2017-04-03       Impact factor: 3.390

5.  The association of ideal cardiovascular health and left ventricle hypertrophy in rural population of northeast China: A cross-sectional observational study.

Authors:  Ye Chang; Yuan Li; Xiaofan Guo; Tan Li; Yintao Chen; Dongxue Dai; Yingxian Sun
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

6.  Female sex and cardiovascular disease risk in rural Uganda: a cross-sectional, population-based study.

Authors:  Itai M Magodoro; Maggie Feng; Crystal M North; Dagmar Vořechovská; John D Kraemer; Bernard Kakuhikire; David Bangsberg; Alexander C Tsai; Mark J Siedner
Journal:  BMC Cardiovasc Disord       Date:  2019-04-25       Impact factor: 2.298

7.  Status of cardiovascular health in the Republic of Serbia: Results from the National Health Survey.

Authors:  Janko Janković; Maša Davidović; Vesna Bjegović-Mikanović; Slavenka Janković
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

8.  Metrics of Ideal Cardiovascular Health are Unequally Distributed between Peruvian Men and Women: Analysis of a National Population-Based Survey in 2017.

Authors:  Akram Hernández-Vásquez; Horacio Chacón-Torrico; Rodrigo Vargas-Fernández; Guido Bendezu-Quispe; Marilina Santero
Journal:  Int J Prev Med       Date:  2020-12-11

9.  Metabolism rather than obesity is associated with ischemic stroke: a cross-sectional study in rural Northeastern China.

Authors:  Zhao Li; Xiaofan Guo; Yamin Liu; Naijin Zhang; Ye Chang; Yintao Chen; Yingxian Sun; Maria Roselle Abraham
Journal:  Springerplus       Date:  2016-08-25

10.  Geographical variations in cardiovascular health in China: A nationwide population-based survey of 74,726 adults.

Authors:  Mei Zhang; Yu Shi; Oumin Shi; Zhenping Zhao; Xiao Zhang; Chun Li; Zhengjing Huang; Liyun Zhao; Limin Wang; Yichong Li; Xinhua Li
Journal:  Lancet Reg Health West Pac       Date:  2020-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.